loadpatents
name:-0.015193939208984
name:-0.012902975082397
name:-0.005155086517334
Waman; Yogesh Patent Filings

Waman; Yogesh

Patent Applications and Registrations

Patent applications and USPTO patent grants for Waman; Yogesh.The latest application filed is for "an improved asymmetric synthesis of azaspiro compounds".

Company Profile
4.15.14
  • Waman; Yogesh - Gujarat IN
  • WAMAN; Yogesh - Ahmedabad Gujarat
  • WAMAN; Yogesh - Maharashtra IN
  • Waman; Yogesh - Pune IN
  • Waman; Yogesh - Hinjewadi Pune IN
  • Waman; Yogesh - Hinjewadi IN
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Asymmetric synthesis of Azaspiro compounds
Grant 11,401,273 - Leleti , et al. August 2, 2
2022-08-02
Asymmetric synthesis of alpha-branched chiral amines
Grant 11,279,672 - Leleti , et al. March 22, 2
2022-03-22
Asymmetric synthesis of alpha-(diarylmethyl) alkyl amines
Grant 11,279,668 - Leleti , et al. March 22, 2
2022-03-22
An Improved Asymmetric Synthesis Of Azaspiro Compounds
App 20220041609 - LELETI; Rajender Reddy ;   et al.
2022-02-10
AN IMPROVED ASYMMETRIC SYNTHESIS OF alpha-BRANCHED CHIRAL AMINES
App 20210114977 - LELETI; Rajender Reddy ;   et al.
2021-04-22
AN IMPROVED ASYMMETRIC SYNTHESIS OF alpha-(DIARYLMETHYL) ALKYL AMINES
App 20210061752 - LELETI; Rajender Reddy ;   et al.
2021-03-04
1-substituted 1,2,3,4-tetrahydro-1,7-naphthyridin-8-amine Derivatives And Their Use As Ep4 Receptor Antagonists
App 20200339577 - BARAWKAR; Dinesh ;   et al.
2020-10-29
1-Substituted 1,2,3,4-tetrahydro-1,7-naphthyridin-8-amine derivatives and their use as EP4 receptor antagonists
Grant 10,745,397 - Barawkar , et al. A
2020-08-18
1-substituted 1,2,3,4-tetrahydro-1,7-naphthyridin-8-amine Derivatives And Their Use As Ep4 Receptor Antagonists
App 20180215754 - BARAWKAR; Dinesh ;   et al.
2018-08-02
Substituted fused tricyclic compounds, compositions, and medicinal applications thereof
Grant 9,593,115 - Barawkar , et al. March 14, 2
2017-03-14
Substituted fused pyrimidine compounds
Grant 9,284,316 - Palle , et al. March 15, 2
2016-03-15
Substituted Fused Tricyclic Compounds, Compositions, And Medicinal Applications Thereof
App 20150239886 - Barawkar; Dinesh ;   et al.
2015-08-27
Substituted fused tricyclic compounds, compositions and medicinal applications thereof
Grant 9,115,133 - Barawkar , et al. August 25, 2
2015-08-25
Substituted Fused Pyrimidine Compounds
App 20150087643 - Palle; Venkata ;   et al.
2015-03-26
Purine compounds as prodrugs of A2B adenosine receptor antagonists, their process and medicinal applications
Grant 8,940,751 - Barawkar , et al. January 27, 2
2015-01-27
Substituted fused pyrimidine compounds
Grant 8,859,566 - Palle , et al. October 14, 2
2014-10-14
Substituted fused pyrimidine compounds, its preparation and uses thereof
Grant 8,796,290 - Ramdas , et al. August 5, 2
2014-08-05
Substituted Fused Tricyclic Compounds, Compositions And Medicinal Applications Thereof
App 20140023614 - Barawkar; Dinesh ;   et al.
2014-01-23
Purine Compounds As Prodrugs Of A2b Adenosine Receptor Antagonists, Their Process And Medicinal Applications
App 20130172249 - Barawkar; Dinesh ;   et al.
2013-07-04
Substituted Fused Pyrimidine Compounds, Its Preparation And Uses Thereof
App 20120225812 - Ramdas; Vidya ;   et al.
2012-09-06
Heterocyclic compounds as adenosine receptor antagonist
Grant 8,252,797 - Palle , et al. August 28, 2
2012-08-28
Substituted Fused Pyrimidine Compounds
App 20120115864 - Palle; Venkata ;   et al.
2012-05-10
Heterocyclic Compounds As Adenosine Receptor Antagonist
App 20090298744 - Palle; Venkata ;   et al.
2009-12-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed